...
首页> 外文期刊>Molecular pharmaceutics >Interplay between Amphiphilic Stabilizers and Cholesterol in the Stabilization of Itraconazole Nanoparticles Prepared by Flash Nanoprecipitation
【24h】

Interplay between Amphiphilic Stabilizers and Cholesterol in the Stabilization of Itraconazole Nanoparticles Prepared by Flash Nanoprecipitation

机译:两亲稳定剂和胆固醇在闪蒸纳米沉淀制备的伊唑康唑纳米粒子稳定之间的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

While flash nanoprecipitation (FNP) has proven to be an extremely rapid and highly efficient nanoparticle fabrication process for hydrophobic drugs, physical instability associated with nonequilibrium molecular orientation of amphiphilic stabilizers (ASs) in nanoparticles remains a major snag in the general application of this nanotechnology, particularly for a drug with ACDLog P in the range of similar to 2-9. This study was aimed at elucidating the costabilizing role of cholesterol (CLT) in the FNP of AS-stabilized nanoparticles of itraconazole (ITZ), a model drug with an ACDLog P of 4.35 +/- 1.22 and log P of 5.66. The presence of CLT was shown to reduce the initial particle size and markedly improve the short-term storage stability of ITZ nanoparticles. The stability-enhancement by CLT can be linked to its higher miscibility or stronger interaction with the AS hydrophobic moiety than with ITZ (as reflected by the absolute differences of their solubility parameter values). Surface analyses employing X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) suggest that, through the coprecipitation of CLT with ITZ to form a mixed hydrophobic drug core, the CLT molecules that are exposed on the core surface serve to afford a stronger and more timely surface anchorage of the AS hydrophobic moieties, thereby facilitating the rearrangement of AS molecules toward the stable micelle-like structure. The present findings offer a mechanistic insight into the interplay between amphiphilic stabilizer and costabilizer in enhancing the physical stability of drug nanoparticles and may carry important implications for the development of more stable and efficacious nanoparticle therapeutics.
机译:虽然闪蒸纳米尺寸(FNP)已被证明是疏水药物的极其快速和高效的纳米粒子制造方法,但纳米颗粒中两亲稳定剂(Ass)的非醌分子取向相关的物理不稳定性仍然是该纳米技术一般应用中的主要障碍,特别是对于具有Acdlog P的药物在类似于2-9的范围内。本研究旨在阐明胆固醇(CLT)在伊唑诺唑(ITZ)的AS稳定的纳米粒子FNP中的苛性山纤维化作用,一种模型药物,其具有4.35 +/- 1.22的ACDLOG P和5.66的log p。显示CLT的存在以降低初始粒度并显着提高ITZ纳米粒子的短期储存稳定性。 CLT的稳定性增强可以与其与作为疏水部分的更高的混溶性或更强的相互作用相比,而不是与ITZ(如其溶解度参数值的绝对差异)相连。采用X射线光电子能谱(XPS)和原子力显微镜(AFM)的表面分析表明,通过CLT与ITZ的COPRECIPIPITITED形成混合的疏水药物,暴露在芯表面上的CLT分子用于负担作为疏水部分的较强更及时的表面锚固,从而促进作为分子朝向稳定的胶束状结构的重新排列。本研究结果提供了对两亲性稳定剂和肋骨增强药物纳米颗粒的物理稳定性之间的相互作用的机械洞察,并且可能对更稳定和有效的纳米颗粒治疗剂进行重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号